Listen to the Take & Tell song
What are side effects?
Side effects, or adverse drug reactions, happen when a treatment goes beyond the desired effect and causes a problem.
What is pharmacovigilance?
Monitoring, assessing and understanding adverse effects, or other drug-related problems, is known as pharmacovigilance, and is essential as long as a medicine remains on the market.
Why does it matter to me?
Reporting suspected adverse reactions offers the opportunity to identify and further investigate unknown or poorly described side effects. It also encourages dialogue between you and your health care professional.
The Take & Tell steps
What to do?
Next time you take your medicine, pay attention to the possible side effects. If you suspect that you have experienced an adverse drug reaction, write it down and talk to your doctor about the symptoms. It is very important that you together discuss about the measures that you should take. You can get started by downloading the Take & Tell application
Download the Take & Tell application
Take & Tell application helps you keep track of any possible side effects to medicines. It’s also a good tool for sharing the information with your doctor.
Explore the global data base of adverse drug reactions
VigiAccess™ is a user-friendly interface that allows you to search VigiBase® ,the WHO global database of reported suspected adverse reactions, and retrieves statistical data on the suspected side effects of medicines reported to the WHO Programme for International Drug Monitoring. VigiBase has over 10 million reports from all over the world and offers you information going back to 1968.
Frequently Asked Questions
Also, low quality and falsified medicines can also cause serious side effects. Telling your doctor about side effects will make drug use safer for everyone. The information you provide contributes to improving the quality of medicines and protecting health.
All reports are anonymous; the patients, healthcare professionals or institutions involved cannot be identified in VigiBase. UMC regularly screens the uploaded data to better identify, characterize and understand the potential risks of the medicine. It then shares the findings with national centres, the WHO and the public via various channels.
Inspire. Engage. Transform
Uppsala Monitoring Centre advances the science of pharmacovigilance and inspires patient safety initiatives all over the world. As an independent, non-profit foundation, we engage stakeholders who share our vision and collaborate to build a global patient safety culture. As a leader in the research and development of new scientific methods, we explore the benefits and risks of medicines to help minimize harm to patients, and offer products and services used by health authorities and life-science companies worldwide. Our unique expertise makes us an organisation with the capacity to transform patient safety from an ambition into a reality. For almost 40 years, we have provided scientific leadership and operational support to the WHO Programme for International Drug Monitoring, expanding the global pharmacovigilance network to reach more than 95% of world’s population.